Comparison Of The Protective Effects Of Selective Endothelin-A Receptor Antagonist Ambrisentan And Dual Endothelin-A/B Receptor Antagonist Bosentan İn Experimental Renal Ischemia Reperfusion Injury
item.page.program
item.page.orgauthor
item.page.kuauthor
item.page.coauthor
Danışman
Tarih
item.page.language
English